Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Nephrotic Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Not applicableStudy completedNCT06071533
What this trial is testing

Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome

Who this might be right for
Acute Kidney InjuryNephrotic SyndromeNephropathy
First Affiliated Hospital of Wenzhou Medical University 441
Post-approval studies (Phase 4)Study completedNCT01162005
What this trial is testing

Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

Who this might be right for
Nephrotic Syndrome
Seoul National University Hospital 77
Testing effectiveness (Phase 2)Study completedNCT05050214
What this trial is testing

Obinutuzumab in Primary MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 20
Early research (Phase 1)Study completedNCT02639260
What this trial is testing

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases

Who this might be right for
Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10
Not applicableNot Yet RecruitingNCT06315504
What this trial is testing

Circulating Factors in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more
Iain Bressendorff 104
Early research (Phase 1)UnknownNCT02382874
What this trial is testing

Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)

Who this might be right for
Focal Segmental Glomerulosclerosis
Royan Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Post-approval studies (Phase 4)Study completedNCT03210688
What this trial is testing

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

Who this might be right for
Minimal Change DiseaseNephrotic Syndrome
University of Aarhus 71
Not applicableLooking for participantsNCT04174066
What this trial is testing

From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP

Who this might be right for
Nephrotic Syndrome
Centre Hospitalier Universitaire de Nice 144
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Not applicableUnknownNCT05679336
What this trial is testing

Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy - PLA2R Induced
St. Petersburg State Pavlov Medical University 40
Post-approval studies (Phase 4)UnknownNCT05772871
What this trial is testing

The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

Who this might be right for
Nephrotic Syndrome in Children
Jianhua Zhou 402
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Not applicableUnknownNCT05623033
What this trial is testing

The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

Who this might be right for
Nephrotic SyndromeInfectionsLymphocyte
Fifth Affiliated Hospital, Sun Yat-Sen University 156
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Ended earlyNCT03703908
What this trial is testing

CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome

Who this might be right for
Focal Segmental Glomerulosclerosis
Amgen 5